House appropriators peg foreign inspections as a key priority for FDA and want the agency to continue efforts to ramp up its overseas inspection enforcement activities, according to the House Appropriations Committee’s fiscal 2022 funding report. The committee specifically directs FDA to use the $5 million increase provided in fiscal 2022 spending legislation to resume its unannounced inspection pilot program in India and set up a similar pilot program in China. Lawmakers also want FDA to continue its efforts to...